Skip to content
  • What the 2016 budget proposal means for antibiotic research

    Popular Science - 02/12/2015

    In recent years, attention has turned back toward antibiotics. The Generating Antibiotic Incentives Now Act went into effect in 2012, allowing for Food and Drug Administration fast-track the approval of new antibiotics and extend patent exclusivity. The measure appears to be working. The FDA approved four new antibiotics in 2014, compared to six antibiotics in the combined ten years before that.

    Things are looking up in the drug discovery process as well. Earlier this year, Kim Lewis, an NIH-funded researcher at Northeastern University contributed a study detailing his discovery of a new antibiotic discovery method. Using a device called the “iChip,” Lewis turned his attention to the soil (where most of the early antibiotics originated) and identified a promising new antibiotic compound called Teixobactin that may have a quality every other antibiotic lacks: “Our compound is different in the way that it doesn’t develop resistance,” says Lewis.

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.